Skandinaviska Enskilda Banken (SEB)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$347K Sell
1,420
-1,092,965
-100% -$255M 0.01% 129
2025
Q4
$226M Buy
1,094,385
+329,501
+43% +$65.2M 0.91% 18
2025
Q3
$142M Buy
764,884
+48,557
+7% +$8.32M 0.57% 30
2025
Q2
$109M Buy
716,327
+59,262
+9% +$9.11M 0.48% 38
2025
Q1
$109M Sell
657,065
-15,943
-2% -$2.49M 0.54% 31
2024
Q4
$96.5M Sell
673,008
-102,441
-13% -$15.9M 0.44% 39
2024
Q3
$126M Sell
775,449
-77,192
-9% -$12.3M 0.58% 33
2024
Q2
$125M Buy
852,641
+31,863
+4% +$4.74M 0.6% 31
2024
Q1
$130M Buy
820,778
+130,537
+19% +$20.8M 0.64% 25
2023
Q4
$108M Buy
690,241
+19,113
+3% +$2.93M 0.63% 27
2023
Q3
$105M Sell
671,128
-192,151
-22% -$31.7M 0.69% 26
2023
Q2
$143M Sell
863,279
-109,678
-11% -$17.7M 0.94% 16
2023
Q1
$151M Buy
972,957
+69,007
+8% +$11.1M 1.05% 13
2022
Q4
$160M Sell
903,950
-41,877
-4% -$7.23M 1.2% 9
2022
Q3
$155M Sell
945,827
-273,774
-22% -$46.3M 1.19% 12
2022
Q2
$216M Sell
1,219,601
-73,551
-6% -$13.1M 1.59% 8
2022
Q1
$229M Sell
1,293,152
-697,831
-35% -$119M 1.35% 11
2021
Q4
$343M Buy
1,990,983
+507,929
+34% +$83.2M 1.77% 6
2021
Q3
$240M Buy
1,483,054
+55,384
+4% +$9.45M 1.31% 8
2021
Q2
$235M Sell
1,427,670
-34,371
-2% -$5.69M 1.44% 6
2021
Q1
$240M Buy
1,462,041
+87,675
+6% +$14.2M 1.58% 6
2020
Q4
$216M Buy
1,374,366
+33,510
+2% +$4.95M 1.49% 7
2020
Q3
$200M Buy
1,340,856
+356,747
+36% +$52.8M 1.46% 8
2020
Q2
$138M Sell
984,109
-117,960
-11% -$17.2M 1.12% 14
2020
Q1
$145M Sell
1,102,069
-14,657
-1% -$2.08M 1.46% 12
2019
Q4
$163M Sell
1,116,726
-213,520
-16% -$29M 1.28% 14
2019
Q3
$172M Buy
1,330,246
+160,150
+14% +$21.1M 1.45% 10
2019
Q2
$163M Buy
1,170,096
+6,946
+0.6% +$961K 1.41% 15
2019
Q1
$163M Sell
1,163,150
-228,150
-16% -$30.6M 1.49% 15
2018
Q4
$180M Sell
1,391,300
-32,188
-2% -$4.49M 1.61% 15
2018
Q3
$197M Sell
1,423,488
-1,211,103
-46% -$161M 1.49% 16
2018
Q2
$320M Sell
2,634,591
-76,184
-3% -$9.5M 2.73% 3
2018
Q1
$347M Sell
2,710,775
-583,962
-18% -$78.9M 3.35% 2
2017
Q4
$460M Buy
3,294,737
+1,062,357
+48% +$148M 3.96% 1
2017
Q3
$290M Buy
2,232,380
+14,508
+0.7% +$1.92M 2.63% 3
2017
Q2
$293M Buy
2,217,872
+133,872
+6% +$17.1M 2.82% 2
2017
Q1
$260M Sell
2,084,000
-1,039,808
-33% -$124M 2.62% 3
2016
Q4
$360M Sell
3,123,808
-13,950
-0.4% -$1.61M 4.32% 1
2016
Q3
$371M Buy
3,137,758
+898,228
+40% +$109M 4.01% 1
2016
Q2
$272M Buy
2,239,530
+104,956
+5% +$11.9M 3.04% 3
2016
Q1
$231M Buy
2,134,574
+194,026
+10% +$20.1M 2.59% 3
2015
Q4
$199M Buy
+1,940,548
New +$195M 2.58% 6

Other funds holding JNJ

Skandinaviska Enskilda Banken (SEB)'s JNJ Position: Q1 2026 in Review

Skandinaviska Enskilda Banken (SEB) reduced its Johnson & Johnson (JNJ) stake by 100% in Q1 2026, selling an estimated $255M and leaving 1,420 shares worth $347K. The position accounts for 0.01% of the portfolio, ranked #129.

Skandinaviska Enskilda Banken (SEB) first reported a position in JNJ in Q4 2015 and has held it in 42 quarters since. The position peaked at $460M in Q4 2017. 4,627 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Skandinaviska Enskilda Banken (SEB) held 1,420 shares of Johnson & Johnson worth $347K as of Q1 2026.
  • Skandinaviska Enskilda Banken (SEB) sold 1,092,965 Johnson & Johnson shares in Q1 2026, an estimated $255M.
  • Johnson & Johnson made up 0.01% of Skandinaviska Enskilda Banken (SEB)'s portfolio in Q1 2026, its #129 holding.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Johnson & Johnson in Q4 2015 and has held it in 42 quarters since.
  • Skandinaviska Enskilda Banken (SEB)'s Johnson & Johnson position peaked at $460M in Q4 2017.
  • 4,627 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.